Country Club Bank trimmed its position in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 15.7% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 9,095 shares of the company's stock after selling 1,695 shares during the quarter. Country Club Bank's holdings in Cardinal Health were worth $1,241,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds have also recently modified their holdings of the company. Investment Management Associates Inc. ADV raised its position in shares of Cardinal Health by 4.9% in the 1st quarter. Investment Management Associates Inc. ADV now owns 7,397 shares of the company's stock worth $1,019,000 after purchasing an additional 343 shares during the last quarter. Allworth Financial LP raised its position in shares of Cardinal Health by 5.5% in the 1st quarter. Allworth Financial LP now owns 3,978 shares of the company's stock worth $540,000 after purchasing an additional 207 shares during the last quarter. Nisa Investment Advisors LLC raised its position in shares of Cardinal Health by 0.3% in the 1st quarter. Nisa Investment Advisors LLC now owns 78,317 shares of the company's stock worth $10,790,000 after purchasing an additional 218 shares during the last quarter. Axxcess Wealth Management LLC purchased a new position in shares of Cardinal Health in the 1st quarter worth about $1,426,000. Finally, Rehmann Capital Advisory Group raised its position in shares of Cardinal Health by 5.5% in the 1st quarter. Rehmann Capital Advisory Group now owns 3,109 shares of the company's stock worth $428,000 after purchasing an additional 163 shares during the last quarter. Institutional investors own 87.17% of the company's stock.
Cardinal Health Stock Down 0.8%
CAH traded down $1.30 during trading on Friday, reaching $160.87. The company had a trading volume of 1,314,182 shares, compared to its average volume of 2,240,077. The business has a 50 day simple moving average of $157.67 and a 200-day simple moving average of $138.75. Cardinal Health, Inc. has a 52 week low of $93.17 and a 52 week high of $168.44. The stock has a market cap of $38.40 billion, a P/E ratio of 25.10, a PEG ratio of 1.61 and a beta of 0.68.
Cardinal Health (NYSE:CAH - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The company reported $2.35 EPS for the quarter, beating the consensus estimate of $2.15 by $0.20. Cardinal Health had a negative return on equity of 68.84% and a net margin of 0.70%. The firm had revenue of $54.88 billion for the quarter, compared to analyst estimates of $55.33 billion. During the same quarter last year, the firm posted $2.08 earnings per share. The business's revenue for the quarter was up .0% on a year-over-year basis. As a group, equities research analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.
Cardinal Health Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be given a dividend of $0.5107 per share. This is a boost from Cardinal Health's previous quarterly dividend of $0.51. This represents a $2.04 annualized dividend and a yield of 1.27%. The ex-dividend date of this dividend is Tuesday, July 1st. Cardinal Health's dividend payout ratio (DPR) is currently 31.83%.
Wall Street Analysts Forecast Growth
A number of brokerages have weighed in on CAH. Mizuho boosted their target price on Cardinal Health from $142.00 to $150.00 and gave the stock an "outperform" rating in a research report on Monday, March 31st. UBS Group upped their price target on shares of Cardinal Health from $150.00 to $160.00 and gave the company a "buy" rating in a research report on Tuesday, April 29th. Evercore ISI reaffirmed an "outperform" rating and set a $180.00 price target (up previously from $175.00) on shares of Cardinal Health in a research report on Thursday, June 12th. Bank of America upped their price target on shares of Cardinal Health from $165.00 to $170.00 and gave the company a "buy" rating in a research report on Tuesday, June 10th. Finally, Citigroup reaffirmed a "neutral" rating and set a $170.00 price target (up previously from $157.00) on shares of Cardinal Health in a research report on Friday, June 13th. Three research analysts have rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $157.43.
Read Our Latest Stock Report on Cardinal Health
Cardinal Health Company Profile
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Recommended Stories

Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.